Abstract 4CPS-123 Table 1
Chemotherapy regimens
XP
DCX
N (%)
171 (78%)
48 (22%)
Overall survival, months (CI 95%) p=0.2099
10.6 (9–12)
11.3 (9–16)
Progression-free survival, months (CI 95%) *p=0.0045
5.6* (5–6)
9.5* (7–12)